Status:
COMPLETED
Evaluating Serum Sex Steroid Hormones
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Validation
Eligibility:
All Genders
20-75 years
Brief Summary
The purpose of this study is to evaluate the reproducibility of measurements of sex hormone levels in serum samples. Researchers will collect blood from 60 healthy adults, including 20 men, 20 premeno...
Detailed Description
This evaluation of the reproducibility of serum sex steroid measurements has two components. The first is the evaluation of reproducibility of laboratory measurements of steroid sex hormones in men. T...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- We plan to recruit healthy men aged 50-65 from Westat employees and family and friends of Westat employees.
- One month later we will recruit 20 pre menopausal women (aged 20-40) and 20 post menopausal women (aged 55-75).
Exclusion
Key Trial Info
Start Date :
August 6 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 25 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00340756
Start Date
August 6 2003
End Date
February 25 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892